01/27/2025
5:19 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:50 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
4:41 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:52 PM | Novavax (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:44 PM | Novavax (Issuer)
YOUNG JAMES F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:47 PM | King Rachel K. (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2025
3:02 PM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144/A | |
12/30/2024
4:27 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2024
9:31 AM | Novavax (Subject)
YOUNG JAMES F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
4:24 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:24 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for NVAX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Novavax and its competitors with MarketBeat's FREE daily newsletter. |
12/13/2024
11:13 AM | King Rachel K. (Reporting)
Novavax (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2024
5:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
3:05 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/13/2024
3:08 PM | Draghia-Akli Ruxandra (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
10:21 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:01 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
12:19 PM | Novavax (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/16/2024
7:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2024
3:08 PM | Dubovsky Filip (Reporting)
Novavax (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:47 PM | Novavax (Issuer)
Trizzino John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
4:06 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
7:04 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:37 AM | Novavax (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024
5:16 AM | Novavax (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
06/20/2024
4:08 PM | Dubovsky Filip (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:35 PM | Novavax (Subject)
SK Bioscience Co., Ltd. (Filed by)
| Form SC 13G/A | |
06/06/2024
6:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
8:35 PM | Novavax (Filer)
| Form DEFA14A | |
05/20/2024
1:42 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form DFAN14A | |
05/20/2024
5:09 AM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form SC 13D/A | |
05/15/2024
8:15 PM | Dubovsky Filip (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2024
1:39 PM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2024
7:05 AM | Novavax (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
7:07 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
3:53 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form DFAN14A | |
05/07/2024
4:21 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form DFAN14A | |
05/07/2024
1:43 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form SC 13D/A | |
05/06/2024
3:43 PM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form DFAN14A | |
05/06/2024
5:00 AM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form PREC14A | |
04/29/2024
6:58 AM | Novavax (Filer)
| Form DEFA14A | |
Is this Elon’s true agenda? (Ad) All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors have all turned to my business partner and I for our thoughts on the market. And with every investor in America wondering what Elon is going to do now that he's in Washington, this is what we tell them Click here for my report |
04/29/2024
7:01 AM | Novavax (Filer)
| Form ARS | |
04/29/2024
6:54 AM | Novavax (Filer)
| Form DEF 14A | |
04/15/2024
11:18 AM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form SC 13D/A | |
04/15/2024
5:00 AM | Novavax (Subject)
SHAH CAPITAL MANAGEMENT (Filed by)
| Form SC 13D | |
03/26/2024
6:00 PM | Casey Mark J (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
6:00 PM | Dubovsky Filip (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
6:01 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
6:02 PM | Novavax (Issuer)
O'Hara Elaine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
6:03 PM | Novavax (Issuer)
Trizzino John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
5:11 PM | Jacobs John C (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:45 PM | Novavax (Issuer)
Trizzino John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:46 PM | Dubovsky Filip (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:46 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:39 PM | Kelly James Patrick (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:40 PM | Novavax (Issuer)
Trizzino John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:40 PM | Dubovsky Filip (Reporting)
Novavax (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:30 PM | Novavax (Issuer)
O'Hara Elaine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
7:07 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:30 AM | Novavax (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
5:02 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
12:59 PM | MORGAN STANLEY (Filed by)
Novavax (Subject)
| Form SC 13G | |
01/31/2024
7:00 AM | Novavax (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
